Kanekiyo M, Itoh N, Kawasaki A, Tanaka J, Nakanishi T, Tanaka K
People with BMI 35+, type 2 diabetes, or urgent medical need for weight loss should discuss standard dosing protocols with their doctor first
Unlike our study, some cases of hypoglycemia and gallbladder disease were reported (20)
Resveratrol administration after prenatal exposure to VPA in rats, resulted in prevention or reduction of autism-like social deficits, pregnant Wistar females received a single intraperitoneal dose of VPA (600 mg/kg) on gestational day 12, while resveratrol was administered subcutaneously at 3.6 mg/kg/day from gestational day 6.518.5
While not intended as a dedicated weight-loss therapy (for significant weight management, we recommend our full program), microdosing can support gradual, sustainable weight control as part of a longevity-focused regimen